Skip to content

Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials

Dírcea Rodrigues

Journal of Complementary Medicine & Alternative Healthcare September 17, 2024 DOI: 10.19080/jcmah.2024.13.555852 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Peer reviewed
Intervention Psilocybin
Topics Psilocybin
Keywords Clinical trial
Key findings Psilocybin shows promise for treating several mental disorders, particularly depression and anxiety, but further research is needed to confirm efficacy and safety.

Abstract

Title: Use of psilocybin in the treatment of mental disorders: systematic review of clinical trials. Objective: To evaluate the high-impact evidence on the neurobiology, efficacy, safety, and feasibility of using psilocybin in the treatment of mental disorders such as depression, anxiety, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), smoking, and alcoholism

Comparable studies

Other systematic reviews and meta-analyses on psilocybin, most cited first.

Study Year Design Participants
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies Patients with cancer- or illness-related anxiety and depression, major depressive... 2020 Systematic review n = 188
Blinding and expectancy confounds in psychedelic randomized controlled trials 2021 Systematic review
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Patients from included clinical trials 2016 Systematic review
The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis People with elevated symptoms of anxiety and depression 2020 Meta-analysis n = 117
Default Mode Network Modulation by Psychedelics: A Systematic Review Participants from included studies 2022 Systematic review

Explore topics